1.1  -0.05 (-4.35%)		04-19 16:00
Open: 1.15 High: 1.19 Volume: 275,160		Pre. Close: 1.15 Low: 1.1 Market Cap: 11(M)

Short term
Mid term
Targets	6-month :	1.69	1-year :	2.03
Resists	First :	1.45	Second :	1.74
Pivot price	1.07
Supports	First :	0.99	Second :	0.82
MAs	MA(5) :	1.17	MA(20) :	1.06
	MA(100) :	1.07	MA(250) :	1.34
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	16.6	D(3) :	21.4
RSI	RSI(14): 52.1
52-week	High :	2.04	Low :	0.88

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ONVO ] has closed below upper band by 43.9%. Bollinger Bands are 94.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.19 - 1.2	1.2 - 1.2
Low:	1.08 - 1.09	1.09 - 1.1
Close:	1.09 - 1.1	1.1 - 1.11

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Mon, 15 Apr 2024
Why Organovo Stock Is Up Today - Organovo Holdings (NASDAQ:ONVO) - Benzinga

Mon, 08 Apr 2024
Organovo (ONVO) Looks Good: Stock Adds 8.4% in Session - Yahoo New Zealand News

Thu, 28 Mar 2024
Top 15 3D Printing Companies in the US - Yahoo Finance Australia

Mon, 25 Mar 2024
Is Organovo Holdings Inc (ONVO) Stock Worth a Buy Monday? - InvestorsObserver

Mon, 18 Mar 2024
Organovo Holdings Inc (ONVO) Stock: What Does the Chart Say Monday? - InvestorsObserver

Thu, 08 Feb 2024
Organovo Holdings Unveils Corporate Presentation Online - TipRanks.com - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	10 (M)
Held by Insiders	9.86e+006 (%)
Held by Institutions	3 (%)
Shares Short	150 (K)
Shares Short P.Month	0 (K)

EPS	-1.95e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-73 %
Return on Assets (ttm)	600 %
Return on Equity (ttm)	-72.8 %
Qtrly Rev. Growth	242000 %
Gross Profit (p.s.)	-106.89
Sales Per Share	-148.97
EBITDA (p.s.)	0
Qtrly Earnings Growth	-2.2 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-17 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.01
Price to Cash Flow	1.57

Dividend	0
Forward Dividend	161880
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.